TW202122369A - A preparing method of diethylamino hydroxybenzoyl hexylbenzoate - Google Patents
A preparing method of diethylamino hydroxybenzoyl hexylbenzoate Download PDFInfo
- Publication number
- TW202122369A TW202122369A TW109142958A TW109142958A TW202122369A TW 202122369 A TW202122369 A TW 202122369A TW 109142958 A TW109142958 A TW 109142958A TW 109142958 A TW109142958 A TW 109142958A TW 202122369 A TW202122369 A TW 202122369A
- Authority
- TW
- Taiwan
- Prior art keywords
- diethylamino
- chemical formula
- benzoate
- preparing
- hydroxybenzyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/06—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/34—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having amino groups and esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
本發明係有關於二乙氨基羥苯甲醯基苯甲酸己酯的製備方法,具體係有關於製備工序容易且可進行商業性大量生產的二乙氨基羥苯甲醯基苯甲酸己酯的製備方法、二乙氨基羥苯甲醯基苯甲酸己酯的晶體粒子製備方法及從中製備的二乙氨基羥苯甲醯基苯甲酸己酯。The present invention relates to a preparation method of diethylamino hydroxybenzyl hexyl benzoate, and specifically relates to the preparation of diethylamino hydroxybenzyl hexyl benzoate, which is easy to prepare and can be mass-produced commercially Method, method for preparing crystal particles of diethylaminohydroxybenzyl hexyl benzoate and diethylaminohydroxybenzylhexyl benzoate prepared therefrom.
包括陽光所含的紫外線在內的所有紫外線為致癌物質。作為國際癌症研究機構的IARC將所有種類的紫外線分類為第一級致癌物質,即,分類為確認誘發癌症的物質。All ultraviolet rays including the ultraviolet rays contained in sunlight are carcinogens. IARC, the International Agency for Research on Cancer, classifies all types of ultraviolet rays as first-level carcinogens, that is, classified as substances that are confirmed to induce cancer.
除了致癌性之外,紫外線還使皮膚、眼睛、免疫系統受損,引起皮膚老化。理論上,不受紫外線,會將老化延遲27倍。尤其,在陽光中包含的較多UV-B(320nm~280nm)引起燒傷,用於紫外線殺菌的UV-C(280nm~100nm)因其能量大而比UV-A(400nm~320nm)或UV-B更有害。並且,據悉,過去被熟知為不太有害的UV-A同樣具有高的能量,致使藉由活性氧的去氧核糖核酸(DNA)有可能受損。受到陽光照射時皮膚曬黑,這可被視為為了從有害物質中保護皮膚而產生的現象。除了皮膚老化、皮膚受損之類的健康危害之外,紫外線還在形成雀斑或斑點等美容方面有害。In addition to carcinogenicity, ultraviolet rays also damage the skin, eyes, and immune system, and cause skin aging. Theoretically, not being exposed to ultraviolet rays will delay aging by 27 times. In particular, more UV-B (320nm ~ 280nm) contained in sunlight causes burns, and UV-C (280nm ~ 100nm) used for ultraviolet sterilization is more energy than UV-A (400nm ~ 320nm) or UV- B is more harmful. Moreover, it is reported that UV-A, which was known to be less harmful in the past, also has high energy, so that deoxyribonucleic acid (DNA) may be damaged by reactive oxygen species. The skin tans when exposed to the sun, which can be regarded as a phenomenon to protect the skin from harmful substances. In addition to health hazards such as skin aging and skin damage, ultraviolet rays are also harmful to beauty such as freckles or spots.
如上所述,紫外線被視為是各種老化和皺紋的主要原因,男女老少被推薦防紫外線劑。防紫外線劑分為物理阻隔劑和化學阻隔劑,物理阻隔劑主要利用使紫外線反射的無機化合物(無機阻隔劑),化學阻隔劑利用將紫外線能量變成熱形態來釋放的組合物(有機阻隔劑)。As mentioned above, ultraviolet rays are regarded as the main cause of various aging and wrinkles, and anti-ultraviolet agents are recommended for men and women of all ages. UV blocking agents are divided into physical blocking agents and chemical blocking agents. Physical blocking agents mainly use inorganic compounds that reflect ultraviolet rays (inorganic blocking agents), and chemical blocking agents use compositions that release ultraviolet energy into heat form (organic blocking agents). .
無機阻隔劑主要使用二氧化鈦(titanium dioxide)和氧化鋅。阻隔效果雖優秀,但存在塗抹時發乾,多量塗抹時產生皮膚浮粉的白濁現象的問題。Inorganic barrier agents mainly use titanium dioxide and zinc oxide. Although the barrier effect is excellent, there is a problem of dryness when applied, and white turbidity of skin floating powder when applied in a large amount.
另一方面,有機阻隔劑與無機阻隔劑不同,其種類非常多樣,但主要使用雙乙基己氧苯酚甲氧苯基三嗪(BEMT,bis-ethylhexyloxyphenol methoxyphenyl triazine)、丁基甲氧基二苯甲醯基甲烷(Butyl Methoxydibenzoylmethane)、二乙氨基羥苯甲醯基苯甲酸己酯(DHHB,Diethylamino hydroxybenzoyl hexyl benzoate)、苯基二苯並咪唑四磺酸酯二鈉(DPDT,disodium phenyl dibenzimidazole tetrasulfonate)等。其中,由以下化學式表示的DHHB作為阻隔UV-A的代表性有機阻隔劑,是巴斯夫(BASF)公司藉由歐洲公開公報第1046391號首次開發的產品,是當前以“Uvinul A plus”的商品名稱在市場上銷售中的產品。 On the other hand, organic barrier agents are different from inorganic barrier agents. Their types are very diverse, but mainly use bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT) and butyl methoxy benzophenone. Butyl Methoxydibenzoylmethane (Butyl Methoxydibenzoylmethane), Diethylamino hydroxybenzoyl hexyl benzoate (DHHB), Disodium phenyl dibenzimidazole tetrasulfonate (DPDT), etc. Among them, DHHB represented by the following chemical formula, as a representative organic blocking agent for blocking UV-A, is the first product developed by BASF through the European Public Bulletin No. 1046391. It is currently the product name "Uvinul A plus" Products that are on sale in the market.
BASF公司藉由國際公開公報WO 03/097578介紹根據以下反應式製備DHHB的方法。 BASF Company introduced the method of preparing DHHB according to the following reaction formula through International Publication WO 03/097578.
但是,該製備方法存在如下問題:在酯化反應(esterification)步驟中使用作為強酸的硫酸,需要在高溫(105~110℃)條件下反應,反應結果物中會產生紅色的雜質,為了脫色,需要使用大量的脫色劑,不僅如此,還需要經過多次的純化過程。However, this preparation method has the following problem: the use of sulfuric acid as a strong acid in the esterification step requires the reaction under high temperature (105-110°C) conditions, and red impurities are produced in the reaction result. In order to decolorize, Need to use a large amount of decolorizing agent, not only that, but also need to go through multiple purification processes.
另一方面,BASF公司在國際公開公報WO 2008/135360中公開使DHHB結晶化的方法。但是,上述專利中公開的結晶化方法為在DHHB的熔點(54℃)上完全溶解之後,重新冷卻到熔點以下,來獲得固體形態的DHHB的方法,粉碎是必不可少的。其難以應用於一般的批量生產設備中,因而大量生產上有限制。因此,需要開發製備工序容易且商業上可進行大量生產的DHHB製備方法。On the other hand, BASF Corporation discloses a method for crystallization of DHHB in International Publication WO 2008/135360. However, the crystallization method disclosed in the above patent is a method in which DHHB is completely dissolved at the melting point (54°C) of DHHB and then cooled to below the melting point to obtain a solid form of DHHB, and pulverization is indispensable. It is difficult to apply to general mass production equipment, so there are restrictions on mass production. Therefore, there is a need to develop a method for preparing DHHB that is easy to prepare and can be mass-produced commercially.
發明要解決的技術問題The technical problem to be solved by the invention
本發明提供可改善在強酸中反應而大量產生紅色雜質來難以脫色的現有的製備方法的二乙氨基羥苯甲醯基苯甲酸己酯的製備方法及從中製備的二乙氨基羥苯甲醯基苯甲酸己酯。The present invention provides a method for preparing diethylaminohydroxybenzylhexyl benzoate which can improve the existing preparation method that reacts in a strong acid to produce a large amount of red impurities and is difficult to decolorize, and a diethylaminohydroxybenzylhexyl benzoate prepared therefrom Hexyl benzoate.
並且,本發明提供既使用少量的脫色劑又可減少純化次數,能夠以高的收率和經濟生產的二乙氨基羥苯甲醯基苯甲酸己酯的製備方法及從中製備的二乙氨基羥苯甲醯基苯甲酸己酯。In addition, the present invention provides a method for preparing diethylamino hydroxybenzyl hexyl benzoate, which can be produced with high yield and economic production, and diethylamino hydroxybenzyl hexyl ester prepared therefrom, which can reduce the number of purifications while using a small amount of decoloring agent. Benzoyl hexyl benzoate.
本發明的技術方案在於:The technical scheme of the present invention is:
本發明提供包括將由以下化學式II表示的N,N-二乙氨基-羥基苯甲醯基-苯甲酸與由以下化學式III表示的化合物進行反應來製備由以下化學式I表示的化合物的步驟的二乙氨基羥苯甲醯基苯甲酸己酯的製備方法。 化學式I 化學式II 化學式III The present invention provides a diethyl group comprising a step of reacting N,N-diethylamino-hydroxybenzyl-benzoic acid represented by the following chemical formula II with a compound represented by the following chemical formula III to prepare a compound represented by the following chemical formula I Preparation method of aminohydroxybenzyl hexyl benzoate. Chemical formula I Chemical formula II Chemical formula III
L為氯、溴、碘、甲磺醯基、甲苯磺醯基、苯磺醯基、三氟甲磺醯基、亞硫酸己酯或己基烷基磺醯基。L is chlorine, bromine, iodine, methanesulfonyl, toluenesulfonyl, benzenesulfonyl, trifluoromethanesulfonyl, hexyl sulfite, or hexylalkylsulfonyl.
並且,本發明提供二乙氨基羥苯甲醯基苯甲酸己酯的晶體粒子製備方法。In addition, the present invention provides a method for preparing crystal particles of diethylaminohydroxybenzylhexyl benzoate.
並且,本發明提供根據上述製備方法製備而成的二乙氨基羥苯甲醯基苯甲酸己酯。In addition, the present invention provides diethylamino hydroxybenzyl hexyl benzoate prepared according to the above preparation method.
以下,列舉本發明的實施方式進行詳細說明,使得本發明所屬技術領域的普通技術人員可容易實施。本發明的實施方式是為了向本發明所屬技術領域的普通技術人員更完整地說明本發明而提供的。因此,本發明的實施方式能夠以多種不同的形態變形,本發明的範圍不局限於以下說明的實施方式。Hereinafter, the embodiments of the present invention will be listed and described in detail, so that those of ordinary skill in the art to which the present invention pertains can be easily implemented. The embodiments of the present invention are provided to explain the present invention more completely to those of ordinary skill in the technical field to which the present invention belongs. Therefore, the embodiment of the present invention can be modified in a variety of different forms, and the scope of the present invention is not limited to the embodiment described below.
在本發明的說明書全文中,當一個部分“包括”另一個結構要素時,除非有特別反對的記載,則意味著還可包括其他結構要素,而不是將其他結構要素排除在外。In the full text of the specification of the present invention, when a part "includes" another structural element, unless there is a special objection, it means that other structural elements may be included instead of excluding other structural elements.
在本發明的說明書全文中,當一個步驟與另一個步驟位於“上”或“之前”時,這不僅包括一個步驟與另一個步驟處於直接時間序列的關係的情況,還可包括與處於如同各個步驟之後的混合步驟,兩個步驟的順序中時間序列順序可改變的間接時間序列關係的情況相同的權利。In the full text of the specification of the present invention, when a step and another step are located "on" or "before", this not only includes the case where one step is in a direct time series relationship with another step, but also includes and is in the same way as each step. The mixed step after the step has the same right in the case of the indirect time series relationship in which the time series sequence can be changed in the order of the two steps.
當提出所提及的含義中固有的製備及物質允許誤差時,在本發明的說明書全文中使用的程度的術語“約”、“實質上”等使用為從其數值或接近於其數值的含義,用於防止昧良心的侵權人不正當地利用為了有利於理解本發明而提及準確或絕對數值的公開內容。本發明說明書全文中使用的術語“~(的)步驟”或“~的步驟”不意味著“用於~的步驟”。When the manufacturing and material tolerances inherent in the mentioned meaning are proposed, the terms "about", "substantially" and the like used in the full text of the specification of the present invention are used as meanings from their value or close to their value. It is used to prevent conscientious infringers from improperly using the disclosure that mentions accurate or absolute values in order to facilitate the understanding of the present invention. The term "~ (of) step" or "~ step" used throughout the specification of the present invention does not mean "a step for ~".
本發明提供包括將由以下化學式II表示的N,N-二乙氨基-羥基苯甲醯基-苯甲酸與由以下化學式III表示的化合物進行反應來製備由以下化學式I表示的化合物的步驟的二乙氨基羥苯甲醯基苯甲酸己酯的製備方法。 化學式I 化學式II 化學式II The present invention provides diethyl including the step of reacting N,N-diethylamino-hydroxybenzyl-benzoic acid represented by the following chemical formula II with a compound represented by the following chemical formula III to prepare a compound represented by the following chemical formula I Preparation method of aminohydroxybenzyl hexyl benzoate. Chemical formula I Chemical formula II Chemical formula II
L為氯、溴、碘、甲磺醯基、甲苯磺醯基、苯磺醯基、三氟甲磺醯基、亞硫酸己酯或己基烷基磺醯基。L is chlorine, bromine, iodine, methanesulfonyl, toluenesulfonyl, benzenesulfonyl, trifluoromethanesulfonyl, hexyl sulfite, or hexylalkylsulfonyl.
根據本發明的一具體例,上述反應可在一鹼性化合物所提供之鹼性環境條件下進行。According to a specific example of the present invention, the above reaction can be carried out under alkaline environmental conditions provided by a basic compound.
具體地,上述鹼性化合物可以為選自由碳酸鉀、碳酸鈉、碳酸氫鉀、碳酸氫鈉、氫氧化鈉及氫氧化鉀組成的群組中的無機鹼。然而,不局限於此。Specifically, the above-mentioned basic compound may be an inorganic base selected from the group consisting of potassium carbonate, sodium carbonate, potassium bicarbonate, sodium bicarbonate, sodium hydroxide, and potassium hydroxide. However, it is not limited to this.
並且,上述鹼性化合物可以為選自由三乙胺、二異丙基乙胺、二乙胺及吡啶組成的組中的有機鹼。然而,不局限於此。In addition, the basic compound may be an organic base selected from the group consisting of triethylamine, diisopropylethylamine, diethylamine, and pyridine. However, it is not limited to this.
並且,根據本發明的一具體例,由上述化學式II表示的化合物可藉由將3-二乙氨苯酚與鄰苯二甲酸酐進行反應來製備而成。然而,不局限於此。Moreover, according to a specific example of the present invention, the compound represented by the above chemical formula II can be prepared by reacting 3-diethylaminophenol with phthalic anhydride. However, it is not limited to this.
並且,根據本發明的一具體例,由上述化學式III表示的化合物可將正己醇作為起始物質來製備而成。Moreover, according to a specific example of the present invention, the compound represented by the above chemical formula III can be prepared using n-hexanol as a starting material.
根據本發明,本發明提供以下化學式I的化合物的晶體粒子製備方法。According to the present invention, the present invention provides a method for preparing crystal particles of the compound of the following chemical formula I.
可將C1~C4乙醇用作結晶化溶劑來進行上述晶體粒子的結晶化。例如,上述結晶化溶劑可以為甲醇、乙醇、n-丙醇、異丙醇、n-丁醇、2-丁醇、異丁醇或t-丁醇。C1-C4 ethanol can be used as a crystallization solvent to perform the crystallization of the above-mentioned crystal particles. For example, the above-mentioned crystallization solvent may be methanol, ethanol, n-propanol, isopropanol, n-butanol, 2-butanol, isobutanol, or t-butanol.
具體地,上述結晶化製備方法可包括以下步驟:Specifically, the above crystallization preparation method may include the following steps:
步驟1),在由上述化學式I表示的二乙氨基羥苯甲醯基苯甲酸己酯的濃縮殘渣中投入上述結晶化溶劑;Step 1) Put the above crystallization solvent into the concentrated residue of diethylamino hydroxybenzyl hexyl benzoate represented by the above chemical formula I;
步驟2),將內部溫度升溫到30~50℃來進行溶解;Step 2), increase the internal temperature to 30~50℃ for dissolution;
步驟3),確認完全溶解之後,以2~4℃/hr的速度緩冷來使結晶慢慢析出,緩冷至內部溫度為15~20℃;Step 3), after confirming complete dissolution, slowly cool at a rate of 2 to 4°C/hr to slowly precipitate crystals, and slowly cool to an internal temperature of 15 to 20°C;
步驟4),以2~4℃/hr的速度緩冷來冷卻至0~5℃,製備晶體粒子。Step 4), slowly cooling at a rate of 2 to 4°C/hr to cool to 0 to 5°C to prepare crystal particles.
根據如上所述的本發明的製備方法,可改善在強酸中反應而大量產生的紅色雜質且難以脫色的現有的二乙氨基羥苯甲醯基苯甲酸己酯製備方法。具體地,本發明既使用少量的脫色劑又可減少純化次數,能夠以高收率製備二乙氨基羥苯甲醯基苯甲酸己酯,可經濟地大量生產。According to the preparation method of the present invention as described above, the existing method for preparing diethylamino hydroxybenzyl hexyl benzoate, which is difficult to decolorize, can improve the red impurities produced in large quantities by reaction in strong acid. Specifically, the present invention not only uses a small amount of decoloring agent but also can reduce the number of purifications, can prepare diethylamino hydroxybenzyl hexyl benzoate with high yield, and can be produced in large quantities economically.
並且,本發明提供根據本發明的製備方法製備而成的二乙氨基羥苯甲醯基苯甲酸己酯晶體粒子。In addition, the present invention provides diethylamino hydroxybenzylhexyl benzoate crystal particles prepared according to the preparation method of the present invention.
本發明的二乙氨基羥苯甲醯基苯甲酸己酯晶體粒子根據本發明的製備方法獲取,以結晶形獲得,因而具有不粉碎而可直接使用的優點。The diethylaminohydroxybenzylhexyl benzoate crystal particles of the present invention are obtained according to the preparation method of the present invention and are obtained in a crystalline form, and therefore have the advantage of being directly used without being crushed.
根據本發明的製備方法製備而成的二乙氨基羥苯甲醯基苯甲酸己酯晶體粒子的平均粒子大小可以為1μm~500μm。具體地,平均粒子大小為10μm~100μm。The average particle size of the diethylamino hydroxybenzylhexyl benzoate crystal particles prepared according to the preparation method of the present invention may be 1 μm to 500 μm. Specifically, the average particle size is 10 μm to 100 μm.
並且,根據本發明的製備方法製備而成的二乙氨基羥苯甲醯基苯甲酸己酯晶體粒子的堆積密度大於0.28g/ml。In addition, the bulk density of the diethylaminohydroxybenzylhexyl benzoate crystal particles prepared according to the preparation method of the present invention is greater than 0.28 g/ml.
並且,根據本發明的製備方法製備而成的二乙氨基羥苯甲醯基苯甲酸己酯晶體粒子的純度為98重量百分比以上。In addition, the purity of the diethylaminohydroxybenzylhexyl benzoate crystal particles prepared according to the preparation method of the present invention is 98% by weight or more.
實施例Example
以下,根據製備例及實施例詳細說明本發明。但是,以下製備例或實施例僅用於例示本發明,本發明的內容不局限於以下製備例或實施例。Hereinafter, the present invention will be described in detail based on preparation examples and examples. However, the following preparation examples or examples are only used to illustrate the present invention, and the content of the present invention is not limited to the following preparation examples or examples.
製備例1.2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸的合成Preparation Example 1. Synthesis of 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid
將3-二乙氨苯酚(1.0kg,7.87mol)、鄰苯二甲酸酐(1.17kg,7.87mol)放入三頸(3-neck)燒瓶之後,與甲苯(5.0L)一同攪拌。將反應器內部溫度升溫至110~115℃,攪拌2小時之後,對冷卻到0~10℃而析出的固體進行過濾,獲得標的化合物(1.7kg,89.9%)。After putting 3-diethylaminophenol (1.0 kg, 7.87 mol) and phthalic anhydride (1.17 kg, 7.87 mol) into a three-neck flask, they were stirred with toluene (5.0 L). The internal temperature of the reactor was raised to 110-115°C, and after stirring for 2 hours, the solid precipitated after cooling to 0-10°C was filtered to obtain the target compound (1.7 kg, 89.9%).
核磁共振光譜資料為1 H NMR(CDCl3 ):12.52(s,1H)、7.91(dd,1H)、7.62(m,2H)、7.33(dd,1H)、6.74(d,1H)、6.13(dd,1H)、6.20(d,1H)、1.16(m,6H)The nuclear magnetic resonance spectrum data is 1 H NMR (CDCl 3 ): 12.52 (s, 1H), 7.91 (dd, 1H), 7.62 (m, 2H), 7.33 (dd, 1H), 6.74 (d, 1H), 6.13 ( dd, 1H), 6.20 (d, 1H), 1.16 (m, 6H)
製備例2-1.1-氯己烷的合成Preparation Example 2-1. Synthesis of 1-chlorohexane
一邊攪拌1-己醇(1.2kg,11.70mol)、二甲基甲醯胺(DMF)(8.5g,0.12mol)一邊將內部溫度維持30℃以下來滴加SOCl2 (2.1kg,17.6mol)。滴加結束之後,將內部溫度升溫到80~90℃來攪拌5小時。確認反應結束之後,冷卻,投入5L的純化水,進行層分離來獲得標的化合物(1.3kg,94.2%)。While stirring 1-hexanol (1.2kg, 11.70mol) and dimethylformamide (DMF) (8.5g, 0.12mol) while maintaining the internal temperature below 30°C, SOCl 2 (2.1kg, 17.6mol) was added dropwise . After completion of the dropping, the internal temperature was raised to 80 to 90°C and stirred for 5 hours. After confirming the completion of the reaction, it was cooled, 5 L of purified water was added, and layer separation was performed to obtain the target compound (1.3 kg, 94.2%).
1 H NMR(CDCl3 ):3.49(t,2H)、1.72(m,2H)、1.28(m,2H)、1.27(m,4H)、0.88(m,3H) 1 H NMR (CDCl 3 ): 3.49 (t, 2H), 1.72 (m, 2H), 1.28 (m, 2H), 1.27 (m, 4H), 0.88 (m, 3H)
製備例2-2.1-溴己烷的合成Preparation Example 2-2. Synthesis of 1-bromohexane
一邊攪拌1-己醇(1.2kg,11.70mol)、四氫呋喃(THF)(6.0L)一邊將內部溫度維持10℃以下來滴加PBr3 (3.2kg,17.6mol)。滴加結束之後,將內部溫度維持到10℃以下來攪拌3小時。確認反應結束之後,投入5L的純化水,進行層分離來獲得標的化合物(1.8kg,91.4%)。While stirring 1-hexanol (1.2 kg, 11.70 mol) and tetrahydrofuran (THF) (6.0 L), PBr 3 (3.2 kg, 17.6 mol) was added dropwise while maintaining the internal temperature below 10°C. After the dropwise addition was completed, the internal temperature was maintained at 10°C or less and stirred for 3 hours. After confirming the completion of the reaction, 5 L of purified water was added, and layer separation was performed to obtain the target compound (1.8 kg, 91.4%).
核磁共振光譜資料為1 H NMR(CDCl3 ):3.40(t,2H)、1.85(m,2H)、1.43(m,2H)、1.31(m,4H)、0.90(m,3H)The nuclear magnetic resonance spectrum data is 1 H NMR (CDCl 3 ): 3.40 (t, 2H), 1.85 (m, 2H), 1.43 (m, 2H), 1.31 (m, 4H), 0.90 (m, 3H)
製備例2-3.甲磺酸己酯的合成Preparation Example 2-3. Synthesis of Hexyl Methanesulfonate
一邊攪拌1-己醇(1.2kg,11.70mol)、三乙胺(2.4kg,23.40mol)、二氯甲烷(12.0L)一邊將內部溫度維持10℃以下來滴加MsCl(1.6kg,14.0mol)。滴加結束之後,將內部溫度維持到10℃以下來攪拌3小時。投入5L的純化水來進行層分離之後,對分離的有機層進行減壓濃縮來獲得標的化合物(1.9kg,88.1%)。While stirring 1-hexanol (1.2kg, 11.70mol), triethylamine (2.4kg, 23.40mol), dichloromethane (12.0L) while maintaining the internal temperature below 10°C, MsCl (1.6kg, 14.0mol) was added dropwise ). After the dropwise addition was completed, the internal temperature was maintained at 10°C or less and stirred for 3 hours. After adding 5 L of purified water to perform layer separation, the separated organic layer was concentrated under reduced pressure to obtain the target compound (1.9 kg, 88.1%).
1 H NMR(CDCl3 ):4.23(t,2H)、3.00(s,3H)、1.75(m,2H)、1.40(m,3H)、1.32(m,3H)、0.90(m,3H) 1 H NMR (CDCl 3 ): 4.23 (t, 2H), 3.00 (s, 3H), 1.75 (m, 2H), 1.40 (m, 3H), 1.32 (m, 3H), 0.90 (m, 3H)
製備例2-4.4-甲基苯磺酸己酯的合成Preparation example 2-4. Synthesis of 4-methylbenzenesulfonate hexyl ester
一邊攪拌1-己醇(1.2kg,11.70mol)、TsCl(2.7kg,14.0mol)、二氯甲烷(12.0L)一邊將內部溫度維持10℃以下來滴加三乙胺(2.4kg,23.40mol)。滴加結束之後,將內部溫度維持到10℃以下來攪拌6小時。投入5L的純化水來進行層分離之後,對分離的有機層進行減壓濃縮來獲得標的化合物(2.8kg,93.2%)。While stirring 1-hexanol (1.2kg, 11.70mol), TsCl (2.7kg, 14.0mol), dichloromethane (12.0L) while maintaining the internal temperature below 10°C, add triethylamine (2.4kg, 23.40mol) dropwise ). After the dropwise addition was completed, the internal temperature was maintained at 10°C or less and stirred for 6 hours. After adding 5 L of purified water to perform layer separation, the separated organic layer was concentrated under reduced pressure to obtain the target compound (2.8 kg, 93.2%).
核磁共振光譜資料為1 H NMR(CDCl3 ):7.78(m,2H)、7.34(m,2H)、4.02(m,2H)、2.45(s,3H)、1.65(m,2H)、1.47-1.04(m,6H)、0.85(m,3H)The nuclear magnetic resonance spectrum data is 1 H NMR (CDCl 3 ): 7.78 (m, 2H), 7.34 (m, 2H), 4.02 (m, 2H), 2.45 (s, 3H), 1.65 (m, 2H), 1.47- 1.04 (m, 6H), 0.85 (m, 3H)
製備例2-5.亞硫酸二己酯的合成Preparation Example 2-5. Synthesis of Dihexyl Sulfite
一邊攪拌1-己醇(1.2kg,11.70mol)、DMF(8.5g,0.12mol)一邊將內部溫度維持30℃以下來滴加SOCl2 (0.7kg,5.9mol)。滴加結束之後,將內部溫度升溫到30~40℃來攪拌8小時。確認反應結束之後,冷卻,投入5L的純化水,進行層分離來獲得標的化合物(1.3kg,90.0%)。While stirring 1-hexanol (1.2 kg, 11.70 mol) and DMF (8.5 g, 0.12 mol), SOCl 2 (0.7 kg, 5.9 mol) was added dropwise while maintaining the internal temperature below 30°C. After completion of the dropping, the internal temperature was raised to 30 to 40°C and stirred for 8 hours. After confirming the completion of the reaction, it was cooled, 5 L of purified water was added, and layer separation was performed to obtain the target compound (1.3 kg, 90.0%).
1 H NMR(CDCl3 ):3.95(m,4H)、1.63(m,4H)、1.27(m,6H)、0.86(m,12H) 1 H NMR (CDCl 3 ): 3.95 (m, 4H), 1.63 (m, 4H), 1.27 (m, 6H), 0.86 (m, 12H)
製備例2-6.硫酸二己酯的合成Preparation Example 2-6. Synthesis of Dihexyl Sulfate
一邊攪拌1-己醇(1.2kg,11.70mol)、DMF(8.5g,0.12mol)一邊將內部溫度維持30℃以下來滴加SO2 Cl2 (0.8kg,5.9mol)。滴加結束之後,將內部溫度升溫到30~40℃來攪拌8小時。確認反應結束之後,冷卻,投入5L的純化水,進行層分離來獲得標的化合物(1.4kg,87.0%)。While stirring 1-hexanol (1.2 kg, 11.70 mol) and DMF (8.5 g, 0.12 mol), SO 2 Cl 2 (0.8 kg, 5.9 mol) was added dropwise while maintaining the internal temperature below 30°C. After completion of the dropping, the internal temperature was raised to 30 to 40°C and stirred for 8 hours. After confirming the completion of the reaction, it was cooled, 5 L of purified water was added, and layer separation was performed to obtain the target compound (1.4 kg, 87.0%).
1 H NMR(CDCl3 ):4.00(m,4H)、1.69(m,4H)、1.30(m,6H)、0.90(m,12H) 1 H NMR (CDCl 3 ): 4.00 (m, 4H), 1.69 (m, 4H), 1.30 (m, 6H), 0.90 (m, 12H)
實施例1:二乙氨基羥苯甲醯基苯甲酸己酯的合成Example 1: Synthesis of diethylamino hydroxybenzyl hexyl benzoate
步驟1:二乙氨基羥苯甲醯基苯甲酸己酯的製備Step 1: Preparation of hexyl diethylaminohydroxybenzyl benzoate
將製備例1中合成的2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸(1.1kg,3.51mol)、製備例2-1中合成的1-氯己烷(0.5kg,4.22mol)、K2 CO3 (0.9kg,7.02mol)與1.65L的DMF攪拌。將內部溫度升溫到100~110℃來攪拌4小時之後,冷卻,使用3.5L的乙酸乙酯、3.5L的純化水提取。在30~50℃的內部溫度下,使用5%木炭(charcoal),對分離的最終有機層進行1小時脫色處理之後,進行減壓濃縮。The 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid (1.1kg, 3.51mol) synthesized in Preparation Example 1 and the 1-chlorohexyl synthesized in Preparation Example 2-1 Alkane (0.5 kg, 4.22 mol), K 2 CO 3 (0.9 kg, 7.02 mol) and 1.65 L of DMF were stirred. After raising the internal temperature to 100-110°C and stirring for 4 hours, it was cooled and extracted with 3.5 L of ethyl acetate and 3.5 L of purified water. At an internal temperature of 30 to 50°C, using 5% charcoal, the final organic layer separated was subjected to a decolorization treatment for 1 hour, and then concentrated under reduced pressure.
步驟2Step 2
在步驟1中獲得的濃縮殘渣中投入相對於2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸占4v/w的甲醇(即為4ml之甲醇與1g之2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸混合)之後,將內部溫度升溫到30~50℃來使其溶解澄清。確認完全溶解之後,以3℃/hr的速度緩冷來使結晶慢慢析出,緩冷至內部溫度為15~20℃。當達到目標溫度時,維持該溫度,攪拌1小時之後,重新以3℃/hr的速度緩冷來冷卻至0~5℃。當達到目標溫度時,維持該溫度,攪拌1小時之後進行過濾來獲得晶體粒子狀態的標的化合物(1.2kg,86.0%)。In the concentrated residue obtained in step 1, 4v/w of methanol (that is, 4ml of methanol and 1g of methanol relative to 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid) was added. After the 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid is mixed), the internal temperature is increased to 30-50°C to make the solution clear. After confirming complete dissolution, it was slowly cooled at a rate of 3°C/hr to slowly precipitate crystals, and then slowly cooled to an internal temperature of 15-20°C. When the target temperature is reached, the temperature is maintained, and after stirring for 1 hour, it is slowly cooled again at a rate of 3°C/hr to cool to 0-5°C. When the target temperature is reached, the temperature is maintained, and after stirring for 1 hour, filtration is performed to obtain the target compound (1.2 kg, 86.0%) in the state of crystal particles.
核磁共振光譜資料為1 H NMR(CDCl3 ):12.59(s,1H)、8.04(dd,1H)、7.55(m,2H)、7.34(dd,1H)、6.87(d,1H)、6.12(d,1H)、6.02(dd,1H)、4.10(t,2H)、3.35(q,4H)、1.45(m,2H)、1.16(m,12H)、0.82(t,3H)The nuclear magnetic resonance spectrum data is 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 ( d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H)
平均粒子大小:80.3μmAverage particle size: 80.3μm
堆積密度:0.34g/mlBulk density: 0.34g/ml
純度:99.4%Purity: 99.4%
實施例2:二乙氨基羥苯甲醯基苯甲酸己酯的合成Example 2: Synthesis of Diethylamino hydroxybenzylhexyl benzoate
在實施例1的步驟1中獲得的濃縮殘渣中投入相對於2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸占4v/w的乙醇(即為4ml之乙醇與1g之2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸混合)之後,將內部溫度升溫到30~50℃來使其溶解澄清。確認完全溶解之後,以3℃/hr的速度緩冷來使結晶慢慢析出,緩冷至內部溫度為15~20℃。當達到目標溫度時,維持該溫度,攪拌1小時之後,重新以3℃/hr的速度緩冷來冷卻至0~5℃。當達到目標溫度時,維持該溫度,攪拌1小時之後進行過濾來獲得晶體粒子狀態的標的化合物(1.1kg,80.0%)。In the concentrated residue obtained in step 1 of Example 1, 4 v/w of ethanol (that is, 4 ml of ethanol) relative to 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid was added. After ethanol is mixed with 1 g of 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid), the internal temperature is raised to 30-50°C to dissolve and clarify. After confirming complete dissolution, it was slowly cooled at a rate of 3°C/hr to slowly precipitate crystals, and then slowly cooled to an internal temperature of 15-20°C. When the target temperature is reached, the temperature is maintained, and after stirring for 1 hour, it is slowly cooled again at a rate of 3°C/hr to cool to 0-5°C. When the target temperature is reached, the temperature is maintained, and after stirring for 1 hour, filtration is performed to obtain the target compound (1.1 kg, 80.0%) in the state of crystal particles.
核磁共振光譜資料為1 H NMR(CDCl3 ):12.59(s,1H)、8.04(dd,1H)、7.55(m,2H)、7.34(dd,1H)、6.87(d,1H)、6.12(d,1H)、6.02(dd,1H)、4.10(t,2H)、3.35(q,4H)、1.45(m,2H)、1.16(m,12H)、0.82(t,3H)The nuclear magnetic resonance spectrum data is 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 ( d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H)
平均粒子大小:73.7μmAverage particle size: 73.7μm
堆積密度:0.32g/mlBulk density: 0.32g/ml
純度:99.6%Purity: 99.6%
實施例3:二乙氨基羥苯甲醯基苯甲酸己酯的合成Example 3: Synthesis of Diethylamino hydroxybenzylhexyl benzoate
在實施例1的步驟1中獲得的濃縮殘渣中投入相對於2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸占4v/w的異丙醇(即為4ml之異丙醇與1g之2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸混合)之後,將內部溫度升溫到30~50℃來使其溶解澄清。確認完全溶解之後,以3℃/hr的速度緩冷來使結晶慢慢析出,緩冷至內部溫度為15~20℃。當達到目標溫度時,維持該溫度,攪拌1小時之後,重新以3℃/hr的速度緩冷來冷卻至0~5℃。當達到目標溫度時,維持該溫度,攪拌1小時之後進行過濾來獲得晶體粒子狀態的標的化合物(1.10kg,80.0%)。The concentrated residue obtained in step 1 of Example 1 was added with isopropanol (4v/w) relative to 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid. After mixing 4ml of isopropanol with 1g of 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid), the internal temperature is raised to 30-50°C to make it dissolve and clarify. After confirming complete dissolution, it was slowly cooled at a rate of 3°C/hr to slowly precipitate crystals, and then slowly cooled to an internal temperature of 15-20°C. When the target temperature is reached, the temperature is maintained, and after stirring for 1 hour, it is slowly cooled again at a rate of 3°C/hr to cool to 0-5°C. When the target temperature is reached, the temperature is maintained, and after stirring for 1 hour, filtration is performed to obtain the target compound (1.10 kg, 80.0%) in the state of crystal particles.
核磁共振光譜資料為1 H NMR(CDCl3 ):12.59(s,1H)、8.04(dd,1H)、7.55(m,2H)、7.34(dd,1H)、6.87(d,1H)、6.12(d,1H)、6.02(dd,1H)、4.10(t,2H)、3.35(q,4H)、1.45(m,2H)、1.16(m,12H)、0.82(t,3H)The nuclear magnetic resonance spectrum data is 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 ( d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H)
平均粒子大小:91.2μmAverage particle size: 91.2μm
堆積密度:0.38g/mlBulk density: 0.38g/ml
純度:99.2%Purity: 99.2%
實施例4:二乙氨基羥苯甲醯基苯甲酸己酯的合成Example 4: Synthesis of Diethylamino hydroxybenzylhexyl benzoate
在實施例1的步驟1中獲得的濃縮殘渣中投入相對於2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸占4v/w的2-丁醇之後,將內部溫度升溫到30~50℃來使其溶解澄清。確認完全溶解之後,以3℃/hr的速度緩冷來使結晶慢慢析出,緩冷至內部溫度為15~20℃。當達到目標溫度時,維持該溫度,攪拌1小時之後,重新以3℃/hr的速度緩冷來冷卻至0~5℃。當達到目標溫度時,維持該溫度,攪拌1小時之後進行過濾來獲得晶體粒子狀態的標的化合物(1.00kg,75.0%)。After adding 4 v/w of 2-butanol to 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid to the concentrated residue obtained in step 1 of Example 1, The internal temperature was raised to 30-50°C to dissolve and clarify. After confirming complete dissolution, it was slowly cooled at a rate of 3°C/hr to slowly precipitate crystals, and then slowly cooled to an internal temperature of 15-20°C. When the target temperature is reached, the temperature is maintained, and after stirring for 1 hour, it is slowly cooled again at a rate of 3°C/hr to cool to 0-5°C. When the target temperature is reached, the temperature is maintained, and after stirring for 1 hour, filtration is performed to obtain the target compound (1.00 kg, 75.0%) in the state of crystal particles.
核磁共振光譜資料為1 H NMR(CDCl3 ):12.59(s,1H)、8.04(dd,1H)、7.55(m,2H)、7.34(dd,1H)、6.87(d,1H)、6.12(d,1H)、6.02(dd,1H)、4.10(t,2H)、3.35(q,4H)、1.45(m,2H)、1.16(m,12H)、0.82(t,3H)The nuclear magnetic resonance spectrum data is 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 ( d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H)
平均粒子大小:12.0μmAverage particle size: 12.0μm
堆積密度:0.28g/mlBulk density: 0.28g/ml
純度:99.5%Purity: 99.5%
實施例5:二乙氨基羥苯甲醯基苯甲酸己酯的合成Example 5: Synthesis of Diethylaminohydroxybenzylhexyl benzoate
將製備例1中合成的2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸(1.1kg,3.51mol)、製備例2-2中合成的1-溴己烷(0.7kg,4.22mol)、K2 CO3 (0.9kg,7.02mol)與1.65L的DMF攪拌。將內部溫度升溫到100~110℃來攪拌4小時之後,冷卻,使用3.5L的乙酸乙酯、3.5L的純化水提取。在30~50℃的內部溫度下,使用5%木炭對分離的最終有機層進行1小時脫色處理之後,進行減壓濃縮。The 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid (1.1kg, 3.51mol) synthesized in Preparation Example 1 and the 1-bromohexyl synthesized in Preparation Example 2-2 Alkane (0.7 kg, 4.22 mol), K 2 CO 3 (0.9 kg, 7.02 mol) and 1.65 L of DMF were stirred. After raising the internal temperature to 100-110°C and stirring for 4 hours, it was cooled and extracted with 3.5 L of ethyl acetate and 3.5 L of purified water. After decolorizing the separated final organic layer using 5% charcoal at an internal temperature of 30-50°C for 1 hour, it was concentrated under reduced pressure.
藉由實施例3的結晶化方法使濃縮殘渣結晶化來獲得晶體粒子狀態的標的化合物(0.90kg,65.0%)。The concentrated residue was crystallized by the crystallization method of Example 3 to obtain the target compound (0.90 kg, 65.0%) in the state of crystal particles.
核磁共振光譜資料為1 H NMR(CDCl3 ):12.59(s,1H)、8.04(dd,1H)、7.55(m,2H)、7.34(dd,1H)、6.87(d,1H)、6.12(d,1H)、6.02(dd,1H)、4.10(t,2H)、3.35(q,4H)、1.45(m,2H)、1.16(m,12H)、0.82(t,3H)The nuclear magnetic resonance spectrum data is 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 ( d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H)
平均粒子大小:69.4μmAverage particle size: 69.4μm
堆積密度:0.32g/mlBulk density: 0.32g/ml
純度:99.4%Purity: 99.4%
實施例6:二乙氨基羥苯甲醯基苯甲酸己酯的合成Example 6: Synthesis of Diethylamino hydroxybenzylhexyl benzoate
將製備例1中合成的2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸(1.1kg,3.51mol)、製備例2-3中合成的甲磺酸己酯(0.8kg,4.22mol)、K2 CO3 (0.9kg,7.02mol)與1.65L的DMF攪拌。將內部溫度升溫到100~110℃來攪拌4小時之後,冷卻,使用3.5L的乙酸乙酯、3.5L的純化水提取。在30~50℃的內部溫度下,使用5%木炭對分離的最終有機層進行1小時脫色處理之後,進行減壓濃縮。The 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid (1.1kg, 3.51mol) synthesized in Preparation Example 1 and the hexane methanesulfonate synthesized in Preparation Example 2-3 The ester (0.8 kg, 4.22 mol), K 2 CO 3 (0.9 kg, 7.02 mol) are stirred with 1.65 L of DMF. After raising the internal temperature to 100-110°C and stirring for 4 hours, it was cooled and extracted with 3.5 L of ethyl acetate and 3.5 L of purified water. After decolorizing the separated final organic layer using 5% charcoal at an internal temperature of 30-50°C for 1 hour, it was concentrated under reduced pressure.
藉由實施例3的結晶化方法使濃縮殘渣結晶化來獲得晶體粒子狀態的標的化合物(0.73kg,52.4%)。The concentrated residue was crystallized by the crystallization method of Example 3 to obtain the target compound (0.73 kg, 52.4%) in the state of crystal particles.
核磁共振光譜資料為1 H NMR(CDCl3 ):12.59(s,1H)、8.04(dd,1H)、7.55(m,2H)、7.34(dd,1H)、6.87(d,1H)、6.12(d,1H)、6.02(dd,1H)、4.10(t,2H)、3.35(q,4H)、1.45(m,2H)、1.16(m,12H)、0.82(t,3H)The nuclear magnetic resonance spectrum data is 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 ( d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H)
平均粒子大小:25.8μmAverage particle size: 25.8μm
堆積密度:0.30g/mlBulk density: 0.30g/ml
純度:99.8%Purity: 99.8%
實施例7:二乙氨基羥苯甲醯基苯甲酸己酯的合成Example 7: Synthesis of Diethylamino hydroxybenzyl hexyl benzoate
將製備例1中合成的2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸(1.1kg,3.51mol)、製備例2-4中合成的4-甲基苯磺酸己酯(1.1kg,4.22mol)、K2 CO3 (0.9kg,7.02mol)與1.65L的DMF攪拌。將內部溫度升溫到100~110℃來攪拌4小時之後,冷卻,使用3.5L的乙酸乙酯、3.5L的純化水提取。在30~50℃的內部溫度下,使用5%木炭對分離的最終有機層進行1小時脫色處理之後,進行減壓濃縮。The 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid (1.1kg, 3.51mol) synthesized in Preparation Example 1 and the 4-methyl group synthesized in Preparation Example 2-4 Stirring hexyl benzenesulfonate (1.1 kg, 4.22 mol), K 2 CO 3 (0.9 kg, 7.02 mol) with 1.65 L of DMF. After raising the internal temperature to 100-110°C and stirring for 4 hours, it was cooled and extracted with 3.5 L of ethyl acetate and 3.5 L of purified water. After decolorizing the separated final organic layer using 5% charcoal at an internal temperature of 30-50°C for 1 hour, it was concentrated under reduced pressure.
藉由實施例3的結晶化方法使濃縮殘渣結晶化來獲得晶體粒子狀態的標的化合物(0.66kg,47.6%)。The concentrated residue was crystallized by the crystallization method of Example 3 to obtain the target compound (0.66 kg, 47.6%) in the state of crystal particles.
核磁共振光譜資料為1 H NMR(CDCl3 ):12.59(s,1H)、8.04(dd,1H)、7.55(m,2H)、7.34(dd,1H)、6.87(d,1H)、6.12(d,1H)、6.02(dd,1H)、4.10(t,2H)、3.35(q,4H)、1.45(m,2H)、1.16(m,12H)、0.82(t,3H)The nuclear magnetic resonance spectrum data is 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 ( d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H)
平均粒子大小:81.3μmAverage particle size: 81.3μm
堆積密度:0.37g/mlBulk density: 0.37g/ml
純度:99.5%Purity: 99.5%
實施例8:二乙氨基羥苯甲醯基苯甲酸己酯的合成Example 8: Synthesis of Diethylamino hydroxybenzylhexyl benzoate
將製備例1中合成的2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸(1.1kg,3.51mol)、製備例2-5中合成的亞硫酸二己酯(1.1kg,4.22mol)、K2 CO3 (0.9kg,7.02mol)與1.65L的DMF攪拌。將內部溫度升溫到100~110℃來攪拌4小時之後,冷卻,使用3.5L的乙酸乙酯、3.5L的純化水提取。在30~50℃的內部溫度下,使用5%木炭對分離的最終有機層進行1小時脫色處理之後,進行減壓濃縮。The 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid (1.1kg, 3.51mol) synthesized in Preparation Example 1 and the dihexyl sulfite synthesized in Preparation Example 2-5 The ester (1.1 kg, 4.22 mol), K 2 CO 3 (0.9 kg, 7.02 mol) were stirred with 1.65 L of DMF. After raising the internal temperature to 100-110°C and stirring for 4 hours, it was cooled and extracted with 3.5 L of ethyl acetate and 3.5 L of purified water. After decolorizing the separated final organic layer using 5% charcoal at an internal temperature of 30-50°C for 1 hour, it was concentrated under reduced pressure.
藉由實施例3的結晶化方法使濃縮殘渣結晶化來獲得晶體粒子狀態的標的化合物(1.12kg,80.0%)。The concentrated residue was crystallized by the crystallization method of Example 3 to obtain the target compound (1.12 kg, 80.0%) in the state of crystal particles.
1 H NMR(CDCl3 ):12.59(s,1H)、8.04(dd,1H)、7.55(m,2H)、7.34(dd,1H)、6.87(d,1H)、6.12(d,1H)、6.02(dd,1H)、4.10(t,2H)、3.35(q,4H)、1.45(m,2H)、1.16(m,12H)、0.82(t,3H) 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H)
平均粒子大小:45.2μmAverage particle size: 45.2μm
堆積密度:0.32g/mlBulk density: 0.32g/ml
純度:99.1%Purity: 99.1%
實施例9:二乙氨基羥苯甲醯基苯甲酸己酯的合成Example 9: Synthesis of Diethylamino hydroxybenzylhexyl benzoate
將製備例1中合成的2-(4-N,N-二乙氨基-2-羥基苯甲醯基)苯甲酸(1.1kg,3.51mol)、製備例2-6中合成的硫酸二己酯(1.2kg,4.22mol)、K2 CO3 (0.9kg,7.02mol)與1.65L的DMF攪拌。將內部溫度升溫到100~110℃來攪拌4小時之後,冷卻,使用3.5L的乙酸乙酯、3.5L的純化水提取。在30~50℃的內部溫度下,使用5%木炭對分離的最終有機層進行1小時脫色處理之後,進行減壓濃縮。The 2-(4-N,N-diethylamino-2-hydroxybenzyl)benzoic acid (1.1kg, 3.51mol) synthesized in Preparation Example 1 and the dihexyl sulfate synthesized in Preparation Example 2-6 (1.2kg, 4.22mol), K 2 CO 3 (0.9kg, 7.02mol) and 1.65L of DMF were stirred. After raising the internal temperature to 100-110°C and stirring for 4 hours, it was cooled and extracted with 3.5 L of ethyl acetate and 3.5 L of purified water. After decolorizing the separated final organic layer using 5% charcoal at an internal temperature of 30-50°C for 1 hour, it was concentrated under reduced pressure.
藉由實施例3的結晶化方法使濃縮殘渣結晶化來獲得晶體粒子狀態的標的化合物(1.09kg,78.0%)。The concentrated residue was crystallized by the crystallization method of Example 3 to obtain the target compound (1.09 kg, 78.0%) in the state of crystal particles.
1 H NMR(CDCl3 ):12.59(s,1H)、8.04(dd,1H)、7.55(m,2H)、7.34(dd,1H)、6.87(d,1H)、6.12(d,1H)、6.02(dd,1H)、4.10(t,2H)、3.35(q,4H)、1.45(m,2H)、1.16(m,12H)、0.82(t,3H) 1 H NMR (CDCl 3 ): 12.59 (s, 1H), 8.04 (dd, 1H), 7.55 (m, 2H), 7.34 (dd, 1H), 6.87 (d, 1H), 6.12 (d, 1H), 6.02 (dd, 1H), 4.10 (t, 2H), 3.35 (q, 4H), 1.45 (m, 2H), 1.16 (m, 12H), 0.82 (t, 3H)
平均粒子大小:82.0μmAverage particle size: 82.0μm
堆積密度:0.39g/mlBulk density: 0.39g/ml
純度:99.4%Purity: 99.4%
如實施例中確認,可根據本發明的製備方法以高收率獲得二乙氨基羥苯甲醯基苯甲酸己酯,可簡化脫色及純化工序,因而可經濟地大量生產。As confirmed in the examples, diethylamino hydroxybenzyl hexyl benzoate can be obtained in a high yield according to the preparation method of the present invention, which can simplify the decolorization and purification process, and thus can be economically mass-produced.
上述的本發明的說明用於例示,本發明所屬技術領域的普通技術人員應當理解在不變更本發明的技術思想或必要特徵的情況下,能夠以其他具體的形態容易變形。因此,應理解為以上描述的多個實施例在所有方面是例示性的,而非限定。例如,以單一型說明的各個結構要素能夠以分散的方式實施,同樣,說明為分散的多個結構要素也能夠以結合的形態實施。The above description of the present invention is for exemplification, and those of ordinary skill in the technical field of the present invention should understand that it can be easily deformed in other specific forms without changing the technical idea or essential features of the present invention. Therefore, it should be understood that the multiple embodiments described above are illustrative in all aspects and not restrictive. For example, each structural element described in a single type can be implemented in a dispersed manner, and similarly, a plurality of structural elements described as dispersed can also be implemented in a combined form.
本發明的範圍由所附的權利要求書表示,而不是上述詳細說明,應解釋為從權利要求書的含義及範圍以及其等同概念導出的所有變更或變形的形態包括在本發明的範圍。The scope of the present invention is indicated by the appended claims rather than the above detailed description, and it should be construed that all changes or modifications derived from the meaning and scope of the claims and their equivalent concepts are included in the scope of the present invention.
本發明的有益效果在於:The beneficial effects of the present invention are:
根據本發明的製備方法,可改善在強酸中反應而大量產生的紅色雜質且難以脫色的現有的二乙氨基羥苯甲醯基苯甲酸己酯製備方法。具體地,本發明既使用少量的脫色劑又可減少純化次數,能夠以高收率製備二乙氨基羥苯甲醯基苯甲酸己酯,可經濟地大量生產。According to the preparation method of the present invention, the existing method for preparing diethylamino hydroxybenzyl hexyl benzoate, which is difficult to decolorize, can improve the red impurities produced by the reaction in strong acid. Specifically, the present invention not only uses a small amount of decoloring agent but also can reduce the number of purifications, can prepare diethylamino hydroxybenzyl hexyl benzoate with high yield, and can be produced in large quantities economically.
無no
Claims (8)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20190126502 | 2019-10-11 | ||
KR10-2019-0161828 | 2019-12-06 | ||
KR1020190161828A KR102179649B1 (en) | 2019-10-11 | 2019-12-06 | A preparing method of diethylamino hydroxybenzoyl hexylbenzoate |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202122369A true TW202122369A (en) | 2021-06-16 |
Family
ID=69154356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW109142958A TW202122369A (en) | 2019-10-11 | 2020-12-04 | A preparing method of diethylamino hydroxybenzoyl hexylbenzoate |
Country Status (6)
Country | Link |
---|---|
JP (3) | JP7195351B2 (en) |
KR (3) | KR102179649B1 (en) |
CN (1) | CN113993838A (en) |
DE (1) | DE112020004927T5 (en) |
TW (1) | TW202122369A (en) |
WO (1) | WO2021071033A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114149339A (en) * | 2021-12-28 | 2022-03-08 | 黄冈美丰化工科技有限公司 | Ultraviolet absorbent, composition, cosmetic and process for preparing cosmetic |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102179649B1 (en) * | 2019-10-11 | 2020-11-18 | (주)에이에스텍 | A preparing method of diethylamino hydroxybenzoyl hexylbenzoate |
US20230357129A1 (en) * | 2020-02-27 | 2023-11-09 | Basf Se | Process for isolating 2-(4'-diethylamino-2'-hydroxybenzoyl)benzoic acid hexyl ester |
CN112479890B (en) * | 2020-11-27 | 2023-09-26 | 苏州亚科科技股份有限公司 | Preparation method of nitro compound |
US20240025841A1 (en) * | 2020-12-18 | 2024-01-25 | Basf Se | Method for obtaining crystalline diethylamino hydroxybenzoyl hexyl benzoate |
CN112679393A (en) * | 2020-12-31 | 2021-04-20 | 江苏科本药业有限公司 | Preparation method of sofosbuvir impurity |
CN115010615B (en) * | 2022-07-14 | 2023-12-08 | 四川沃肯精细化工有限公司 | Preparation method of diethylamino hydroxybenzoyl n-hexyl benzoate |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0342665A3 (en) * | 1988-05-20 | 1990-08-16 | Takeda Chemical Industries, Ltd. | Physiologically active substance tan-931, its derivatives, their production and use |
JPH0733709A (en) * | 1993-07-27 | 1995-02-03 | Tanabe Seiyaku Co Ltd | Production of oxalic acid monoester compound |
KR100236388B1 (en) * | 1995-11-28 | 1999-12-15 | 성재갑 | Novel uv-light screening polymers and their preparation method |
DE19917906A1 (en) * | 1999-04-20 | 2000-10-26 | Basf Ag | Use of amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations |
DE10011317A1 (en) * | 2000-03-10 | 2001-09-13 | Basf Ag | Use of amino-substituted hydroxybenzophenones as photoprotective agents and stabilizers for nonliving organic materials, especially plastics, polymer dispersions, lacquers and photographic emulsions |
DE10221805A1 (en) * | 2002-05-15 | 2003-11-27 | Basf Ag | Production of 2-(4-N,N-dialkylamino-2-hydroxybenzoyl)benzoic acid esters, useful for the production of UV-A absorbers, comprises purification of the product ester by treatment with an adsorbent and/or by distillation |
DE10342861A1 (en) * | 2003-09-15 | 2005-04-21 | Basf Ag | Powdered preparations containing a mixture of 2,4,6-trianilino-p- (carbo-2'-ethylhexyl-1'-oxi) -1,3,5-triazine and diethylamino-hydroxybenzoyl-hexyl-benzoate |
US8802887B2 (en) * | 2007-05-02 | 2014-08-12 | Basf Se | Method for the crystallization of 2-(4-N,N-diethyl amino-2-hydroxy benzoyl)-benzoic acid-N-hexyl ester |
KR20110018383A (en) * | 2008-05-21 | 2011-02-23 | 더 리젠트스 오브 더 유니버시티 오브 콜로라도 | Ionic liquids and methods for using the same |
JP4299878B1 (en) * | 2008-10-06 | 2009-07-22 | 株式会社パラエルモサ | Cosmetics |
EP2517689A1 (en) * | 2009-12-24 | 2012-10-31 | Kao Corporation | Hydrogel particles |
JP2014210715A (en) * | 2013-04-17 | 2014-11-13 | ロート製薬株式会社 | Aminohydroxybenzophenone derivative, method for producing the same and ultraviolet absorber and skin external preparation using the same |
HUE054876T2 (en) * | 2015-11-04 | 2021-10-28 | Otsuka Pharma Co Ltd | Innovative preparation and crystallization of iosimenol |
KR102179649B1 (en) * | 2019-10-11 | 2020-11-18 | (주)에이에스텍 | A preparing method of diethylamino hydroxybenzoyl hexylbenzoate |
-
2019
- 2019-12-06 KR KR1020190161828A patent/KR102179649B1/en active IP Right Grant
-
2020
- 2020-03-02 DE DE112020004927.2T patent/DE112020004927T5/en active Pending
- 2020-03-02 WO PCT/KR2020/002959 patent/WO2021071033A1/en active Application Filing
- 2020-03-02 CN CN202080042581.9A patent/CN113993838A/en active Pending
- 2020-03-02 JP JP2020573548A patent/JP7195351B2/en active Active
- 2020-05-14 KR KR1020200057898A patent/KR102357197B1/en active IP Right Grant
- 2020-12-04 TW TW109142958A patent/TW202122369A/en unknown
-
2021
- 2021-11-15 KR KR1020210156960A patent/KR102439837B1/en active IP Right Grant
-
2022
- 2022-09-28 JP JP2022154975A patent/JP2022188148A/en not_active Withdrawn
- 2022-09-28 JP JP2022154976A patent/JP2022188149A/en not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114149339A (en) * | 2021-12-28 | 2022-03-08 | 黄冈美丰化工科技有限公司 | Ultraviolet absorbent, composition, cosmetic and process for preparing cosmetic |
CN114149339B (en) * | 2021-12-28 | 2023-01-31 | 黄冈美丰化工科技有限公司 | Ultraviolet absorbent, composition, cosmetic and process for preparing cosmetic |
WO2023125475A1 (en) * | 2021-12-28 | 2023-07-06 | 黄冈美丰化工科技有限公司 | Ultraviolet absorber, composition, cosmetic product, and process for preparing cosmetic product |
Also Published As
Publication number | Publication date |
---|---|
JP2021533088A (en) | 2021-12-02 |
KR20200002720A (en) | 2020-01-08 |
KR20210142575A (en) | 2021-11-25 |
KR102357197B1 (en) | 2022-02-03 |
CN113993838A (en) | 2022-01-28 |
KR102439837B1 (en) | 2022-09-05 |
KR20210071804A (en) | 2021-06-16 |
JP2022188148A (en) | 2022-12-20 |
WO2021071033A1 (en) | 2021-04-15 |
JP7195351B2 (en) | 2022-12-23 |
WO2021071033A9 (en) | 2021-10-14 |
JP2022188149A (en) | 2022-12-20 |
DE112020004927T5 (en) | 2022-06-23 |
KR102179649B1 (en) | 2020-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW202122369A (en) | A preparing method of diethylamino hydroxybenzoyl hexylbenzoate | |
Haitjema et al. | New photoresponsive (meth) acrylate (co) polymers containing azobenzene pendant sidegroups with carboxylic and dimethylamino substituents—I. Synthesis and characterization of the monomers | |
US5106997A (en) | Squarylium derivatives and preparation thereof | |
US4062854A (en) | Process for preparing N-substituted-8,13-dioxodinaphtho-(2,1-b; 2',3'-di-fluran-6-carboxamides | |
JPH03112950A (en) | Squarylium derivative and production thereof | |
EP1537049A1 (en) | Method of producing crystalline lithium/vanadium oxide powder | |
JPS63113429A (en) | Organic nonlinear optical material | |
CN109134385B (en) | Method for purifying uracil compounds | |
JP2819826B2 (en) | Cyclobutenedione derivative and method for producing the same | |
JPS62149679A (en) | Hydroxyphenylpropionic acid ester having novel crystal structure and production thereof | |
JPH04202167A (en) | Cyclobutenedione derivative and its production | |
JP2819827B2 (en) | Cyclobutenedione derivative and method for producing the same | |
JP7432282B2 (en) | A novel dihydroxaphosphaphenanthrene derivative having a triazine ring and exhibiting a high refractive index and its production method | |
TW480253B (en) | Efficient synthesis of a 1,4-dihydro-2H-3,1-benzoxazin-2-one | |
JPH03271247A (en) | Production of fumaric acid | |
Horner et al. | Syntheses of diacetylene monomers from N‐(nitrophenyl) amine substituted diacetylene alcohols | |
CN116768887A (en) | Preparation method of iridescent and dual-band fluorescent emission material | |
CN103641769B (en) | The preparation method of isoindoline hydrochloride | |
JPH08119914A (en) | Cyclobutendione derivative, its production and nonlinear optical element using the same | |
JPH02196765A (en) | Production of (-)-n-(2,2,5,5-tetramethylcyclopentanecarbonyl)alanine amide | |
JPS58121251A (en) | Preparation of 5-(2-(dialkylamino)ethoxy)carvacrol acetate hydrochloride | |
JPS59122449A (en) | Preparation of aromatic carboxylic acid amide derivative | |
JPS62255454A (en) | Production of 2-(4,4'-bis(dimethylamino)-benzohydryl)-5-dimethylaminobenz-oic acid | |
JPH0436731A (en) | Novel aromatic nonlinear optical material | |
CN109535184A (en) | A kind of method that clavulanic acid t-octanylamine prepares potassium clavulanate |